These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 19396003)

  • 1. Efficacy of megestrol acetate (megace) in the treatment of patients with early endometrial adenocarcinoma: our experiences with 21 patients.
    Eftekhar Z; Izadi-Mood N; Yarandi F; Shojaei H; Rezaei Z; Mohagheghi S
    Int J Gynecol Cancer; 2009 Feb; 19(2):249-52. PubMed ID: 19396003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pregnancy outcome in patients with stage 1a endometrial adenocarcinoma, who conservatively treated with megestrol acetate.
    Shirali E; Yarandi F; Eftekhar Z; Shojaei H; Khazaeipour Z
    Arch Gynecol Obstet; 2012 Mar; 285(3):791-5. PubMed ID: 21805142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Occult myometrial recurrence after progesterone therapy to preserve fertility in a young patient with endometrial cancer.
    Hurst SA; Hartzfeld KM; Del Priore G
    Fertil Steril; 2008 Mar; 89(3):724.e1-3. PubMed ID: 17570366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective study of fertility-sparing treatment with megestrol acetate following hysteroscopic curettage for well-differentiated endometrioid carcinoma and atypical hyperplasia in young women.
    Shan BE; Ren YL; Sun JM; Tu XY; Jiang ZX; Ju XZ; Zang RY; Wang HY
    Arch Gynecol Obstet; 2013 Nov; 288(5):1115-23. PubMed ID: 23644919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conservative treatment with progestin and pregnancy outcomes in endometrial cancer.
    Hahn HS; Yoon SG; Hong JS; Hong SR; Park SJ; Lim JY; Kwon YS; Lee IH; Lim KT; Lee KH; Shim JU; Mok JE; Kim TJ
    Int J Gynecol Cancer; 2009 Aug; 19(6):1068-73. PubMed ID: 19820370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ovarian metastasis in a nulliparous woman with endometrial adenocarcinoma failing conservative hormonal treatment.
    Huang SY; Jung SM; Ng KK; Chang YC; Lai CH
    Gynecol Oncol; 2005 May; 97(2):652-5. PubMed ID: 15863173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fertility-preserving treatment in young patients with endometrial adenocarcinoma.
    Wang CB; Wang CJ; Huang HJ; Hsueh S; Chou HH; Soong YK; Lai CH
    Cancer; 2002 Apr; 94(8):2192-8. PubMed ID: 12001117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of conservative therapy for young women with early endometrial adenocarcinoma.
    Mao Y; Wan X; Chen Y; Lv W; Xie X
    Fertil Steril; 2010 Jan; 93(1):283-5. PubMed ID: 19962142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hysteroscopic Resection in Fertility-Sparing Surgery for Atypical Hyperplasia and Endometrial Cancer: Safety and Efficacy.
    De Marzi P; Bergamini A; Luchini S; Petrone M; Taccagni GL; Mangili G; Colombo G; Candiani M
    J Minim Invasive Gynecol; 2015; 22(7):1178-82. PubMed ID: 26092080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Well-differentiated endometrial adenocarcinoma in an infertility patient with later conception. A case report.
    Kowalczyk CL; Malone J; Peterson EP; Jacques SM; Leach RE
    J Reprod Med; 1999 Jan; 44(1):57-60. PubMed ID: 9987742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormonal therapy for women with stage IA endometrial cancer of all grades.
    Park JY; Kim DY; Kim TJ; Kim JW; Kim JH; Kim YM; Kim YT; Bae DS; Nam JH
    Obstet Gynecol; 2013 Jul; 122(1):7-14. PubMed ID: 23743459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progestin re-treatment in patients with recurrent endometrial adenocarcinoma after successful fertility-sparing management using progestin.
    Park JY; Lee SH; Seong SJ; Kim DY; Kim TJ; Kim JW; Kim JH; Kim YM; Kim YT; Bae DS; Nam JH
    Gynecol Oncol; 2013 Apr; 129(1):7-11. PubMed ID: 23283299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pregnant rate and pregnancy-relating factors of patients with early endometrial carcinoma and severe atypical hyperplasia of endometrium after fertility-preserving treatment by progestin].
    Cao DY; Yu M; Yang JX; Shen K; Huang HF; Cheng NH; Sun ZY; Deng CY; Yu Q; He FF
    Zhonghua Fu Chan Ke Za Zhi; 2013 Jul; 48(7):519-22. PubMed ID: 24284224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathologic characteristics and treatment features of women with the incidental diagnosis of endometrial adenocarcinoma during infertility follow-up in Ankara, Turkey.
    Gungor T; Cetinkaya N; Yalcin H; Zergeroglu S; Erkaya S
    Taiwan J Obstet Gynecol; 2016 Jun; 55(3):309-13. PubMed ID: 27343306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pregnancy outcomes after fertility-sparing management in young women with early endometrial cancer.
    Park JY; Seong SJ; Kim TJ; Kim JW; Kim SM; Bae DS; Nam JH
    Obstet Gynecol; 2013 Jan; 121(1):136-42. PubMed ID: 23262938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fertility-sparing management of low-grade endometrial stromal sarcoma: analysis of an institutional series and review of the literature.
    Laurelli G; Falcone F; Scaffa C; Messalli EM; Del Giudice M; Losito S; Greggi S
    Eur J Obstet Gynecol Reprod Biol; 2015 Dec; 195():61-66. PubMed ID: 26476800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fertility-Sparing Treatment of Early Endometrial Cancer and Complex Atypical Hyperplasia in Young Women of Childbearing Potential.
    Pronin SM; Novikova OV; Andreeva JY; Novikova EG
    Int J Gynecol Cancer; 2015 Jul; 25(6):1010-4. PubMed ID: 25950126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fertility sparing treatment of complex atypical hyperplasia and low grade endometrial cancer using oral progestin.
    Simpson AN; Feigenberg T; Clarke BA; Gien LT; Ismiil N; Laframboise S; Massey C; Ferguson SE
    Gynecol Oncol; 2014 May; 133(2):229-33. PubMed ID: 24561246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A successful live twin birth by in vitro fertilization after conservative treatment of recurrent endometrial cancer.
    Wu HM; Lai CH; Huang HY; Wang HS; Soong YK
    Chang Gung Med J; 2008; 31(1):102-6. PubMed ID: 18419059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reevaluating the safety of fertility-sparing hormonal therapy for early endometrial cancer.
    Yang YC; Wu CC; Chen CP; Chang CL; Wang KL
    Gynecol Oncol; 2005 Nov; 99(2):287-93. PubMed ID: 16051341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.